APA (7th ed.) Citation

Liu, X., Qi, Y., Huang, T., Huang, L., Zhao, M., Wang, Z., . . . Lin, J. Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Liu, Xiao-Qiang, et al. Efficacy, Immunogenicity, and Safety of Heterologous Boosting with a Novel Chimera Chinese MRNA (RQ3013) SARS-CoV-2 Vaccine: A Randomized, Double-blind, Active-controlled Trial. Taylor & Francis Group.

MLA (9th ed.) Citation

Liu, Xiao-Qiang, et al. Efficacy, Immunogenicity, and Safety of Heterologous Boosting with a Novel Chimera Chinese MRNA (RQ3013) SARS-CoV-2 Vaccine: A Randomized, Double-blind, Active-controlled Trial. Taylor & Francis Group.